Hiro Makino in Eureka, California

Medical School: Sorry, his university is not listed
Graduation Year: 1977
The Primary Medical Specialty for Hiro Makino is listed as: Cardiovascular Disease (cardiology)
Approximate Years of Experience: 48
PAC (PECOS ID)#: 4688564792
NPI #: 1467494732
NPI Created On: 06/12/2006
NPI Last Updated Listed as: 11/08/2021
Primary Taxonomy Code: 207RC0000X
License Number:
MD5668
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Hawaii Medical Service Association
• Medicare

Languages spoken by staff include: JAPANESE.

Services and Procedures include:

1. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
2. Routine ekg using at least 12 leads including interpretation and report
3. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision
4. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision
5. Exercise or drug-induced heart and blood vessel stress test with ekg tracing and monitoring
6. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report
7. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
8. Follow-up or limited ultrasound examination of heart
9. Follow-up or limited heart doppler ultrasound study of heart blood flow, valves, and chambers
10. Doppler ultrasound study of color-directed heart blood flow, rate, and valve function
11. Established patient office or other outpatient visit, typically 15 minutes
12. Established patient office or other outpatient, visit typically 25 minutes
13. Initial hospital inpatient care, typically 30 minutes per day
14. Subsequent hospital inpatient care, typically 25 minutes per day
15. Subsequent hospital inpatient care, typically 35 minutes per day
16. Technetium tc-99m sestamibi, diagnostic, per study dose
17. Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic
18. Injection, regadenoson, 0.1 mg